United Services Automobile Association Has $12.12 Million Stake in Agilent Technologies Inc (A)
United Services Automobile Association increased its stake in shares of Agilent Technologies Inc (NYSE:A) by 54.4% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 171,792 shares of the medical research company’s stock after acquiring an additional 60,530 shares during the period. United Services Automobile Association owned 0.05% of Agilent Technologies worth $12,118,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. OppenheimerFunds Inc. increased its holdings in shares of Agilent Technologies by 64.0% during the 2nd quarter. OppenheimerFunds Inc. now owns 7,636,621 shares of the medical research company’s stock valued at $472,248,000 after acquiring an additional 2,980,216 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of Agilent Technologies by 16.9% during the 3rd quarter. American Century Companies Inc. now owns 5,359,933 shares of the medical research company’s stock valued at $378,090,000 after acquiring an additional 774,771 shares during the last quarter. Pictet Asset Management Ltd. increased its holdings in shares of Agilent Technologies by 26.9% during the 3rd quarter. Pictet Asset Management Ltd. now owns 2,350,857 shares of the medical research company’s stock valued at $165,829,000 after acquiring an additional 498,430 shares during the last quarter. Schwab Charles Investment Management Inc. increased its holdings in shares of Agilent Technologies by 3.9% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,329,409 shares of the medical research company’s stock valued at $82,211,000 after acquiring an additional 49,527 shares during the last quarter. Finally, Morgan Stanley grew its holdings in Agilent Technologies by 67.6% in the 2nd quarter. Morgan Stanley now owns 1,227,627 shares of the medical research company’s stock valued at $75,917,000 after buying an additional 495,160 shares during the last quarter.
A opened at $70.25 on Friday. The company has a market capitalization of $22.92 billion, a price-to-earnings ratio of 25.18, a price-to-earnings-growth ratio of 2.01 and a beta of 1.36. The company has a current ratio of 3.29, a quick ratio of 2.74 and a debt-to-equity ratio of 0.39. Agilent Technologies Inc has a 12-month low of $60.42 and a 12-month high of $75.11.
Agilent Technologies announced that its Board of Directors has approved a share buyback program on Monday, November 19th that permits the company to repurchase $1.75 billion in shares. This repurchase authorization permits the medical research company to buy up to 8.8% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s management believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 23rd. Shareholders of record on Monday, December 31st will be given a $0.164 dividend. The ex-dividend date of this dividend is Friday, December 28th. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.93%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.15. Agilent Technologies’s dividend payout ratio (DPR) is currently 21.51%.
In other Agilent Technologies news, insider Dominique Grau sold 8,902 shares of the firm’s stock in a transaction that occurred on Monday, December 3rd. The stock was sold at an average price of $74.00, for a total value of $658,748.00. Following the completion of the sale, the insider now owns 103,387 shares in the company, valued at approximately $7,650,638. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Rodney Gonsalves sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $71.06, for a total value of $106,590.00. The disclosure for this sale can be found here. Insiders sold a total of 34,683 shares of company stock valued at $2,499,491 in the last quarter.
A has been the topic of a number of research analyst reports. Goldman Sachs Group raised Agilent Technologies from a “buy” rating to a “conviction-buy” rating in a report on Monday, September 17th. ValuEngine lowered Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. Morgan Stanley raised their target price on Agilent Technologies from $86.00 to $89.00 and gave the company an “overweight” rating in a report on Tuesday, November 20th. Cleveland Research lowered Agilent Technologies from a “buy” rating to a “neutral” rating in a report on Monday, November 12th. Finally, Deutsche Bank raised their target price on Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, August 15th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $78.75.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Featured Article: How to Use the New Google Finance Tool
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.